Abobaker S. & Kulbe H. & Taube E. T. & Darb-Esfahani S. & Richter R. & Denkert C. & Jank P. & Sehouli J. & Braicu E. I. (2022) Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer. in: Anticancer research (42) 10.21873/anticanres.15650
Al Kawas H. & Saaid I. & Jank P. & Westhoff C. C. & Denkert C. & Pross T. & Weiler K. B. S. & Karsten M. M. (2022) How VEGF-A and its splice variants affect breast cancer development - clinical implications in: Cellular Oncology (Dordrecht) (45) 10.1007/s13402-022-00665-w
Baez-Navarro X. & Salgado R. & Denkert C. & Lennerz J. K. & Penault-Llorca F. & Viale G. & Bartlett J. M. S. & van Deurzen C. H. M. (2022) Selecting patients with HER2-low breast cancer: Getting out of the tangle in: European Journal of Cancer (Oxford, England: 1990) (175) 10.1016/j.ejca.2022.08.022
Bartsch D. K. & Windel S. & Kanngießer V. & Jesinghaus M. & Holzer K. & Rinke A. & Maurer E. (2022) Vessel-Sparing Lymphadenectomy Should Be Performed in Small Intestine Neuroendocrine Neoplasms in: Cancers (14) 10.3390/cancers14153610
Blenman K. R. M. & Marczyk M. & Karn T. & Qing T. & Li X. & Gunasekharan V. & Yaghoobi V. & Bai Y. & Ibrahim E. Y. & Park T. & Silber A. & Wolf D. M. & Reisenbichler E. & Denkert C. & Sinn B. V. & Rozenblit M. & Foldi J. & Rimm D. L. & Loibl S. & Pusztai L. (2022) Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer in: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research (28) 10.1158/1078-0432.CCR-21-3215
Blohmer J.-U. & Link T. & Reinisch M. & Just M. & Untch M. & Stötzer O. & Fasching P. A. & Schneeweiss A. & Wimberger P. & Seiler S. & Huober J. & Thill M. & Jackisch C. & Rhiem K. & Solbach C. & Hanusch C. & Seither F. & Denkert C. & Engels K. & Nekljudova V. & Loibl S. & GBG and AGO-B (2022) Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial in: JAMA Oncology (8) 10.1001/jamaoncol.2022.1059
Bonaterra G. A. & Schleper A. & Skowronek M. & Kilian L. S. & Rink T. & Schwarzbach H. & Heers H. & Hänze J. & Rexin P. & Ramaswamy A. & Denkert C. & Wilhelm B. & Hegele A. & Hofmann R. & Weihe E. & Kinscherf R. (2022) Increased Density of Growth Differentiation Factor-15+ Immunoreactive M1/M2 Macrophages in Prostate Cancer of Different Gleason Scores Compared with Benign Prostate Hyperplasia in: Cancers (14) 10.3390/cancers14194591
Denkert C. & Lebeau A. & Schildhaus H. U. & Jackisch C. & Rüschoff J. (2022) [New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis] in: Pathologie (Heidelberg, Germany) (43) 10.1007/s00292-022-01124-x
Denkert C. & Loibl S. (2022) Response-based molecular subtyping-emergence of the third generation of breast cancer subtypes in: Cancer Cell (40) 10.1016/j.ccell.2022.05.012
Denkert C. & Romey M. & Swedlund B. & Hattesohl A. & Teply-Szymanski J. & Kommoss S. & Kaiser K. & Staebler A. & du Bois A. & Grass A. & Knappmeyer C. & Heitz F. & Solimeno C. & Ebel T. & Harter P. & Marmé F. & Jank P. & Gaiser T. & Neff C. & Wagner U. & Timms K. M. & Rodepeter F. (2022) Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling in: The Journal of molecular diagnostics: JMD (24) 10.1016/j.jmoldx.2022.09.004
Di Fazio P. & Rusche F. D. & Roth S. & Pehl A. & Wächter S. & Mintziras I. & Bartsch D. K. & Holzer K. (2022) Long Non-Coding RNA H19 Expression Correlates with Autophagy Process in Adrenocortical Carcinoma in: Cancer Investigation (40) 10.1080/07357907.2021.2001483
Dixon-Douglas J. & Loibl S. & Denkert C. & Telli M. & Loi S. (2022) Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer in: American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting (42) 10.1200/EDBK_351186
Eilsberger F. & Luster M. & Librizzi D. & Rodepeter F. & Holzer K. & Pfestroff A. (2022) Medullary Thyroid Carcinoma presenting as an Incidentaloma on Gallium-68-PSMA-PET/CT - Systematic Literature Review and Case Report in: Nuklearmedizin. Nuclear Medicine (61) 10.1055/a-1896-0106
Falcomatà C. & Bärthel S. & Widholz S. A. & Schneeweis C. & Montero J. J. & Toska A. & Mir J. & Kaltenbacher T. & Heetmeyer J. & Swietlik J. J. & Cheng J.-Y. & Teodorescu B. & Reichert O. & Schmitt C. & Grabichler K. & Coluccio A. & Boniolo F. & Veltkamp C. & Zukowska M. & Vargas A. A. & Paik W. H. & Jesinghaus M. & Steiger K. & Maresch R. & Öllinger R. & Ammon T. & Baranov O. & Robles M. S. & Rechenberger J. & Kuster B. & Meissner F. & Reichert M. & Flossdorf M. & Rad R. & Schmidt-Supprian M. & Schneider G. & Saur D. (2022) Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment in: Nature Cancer (3) 10.1038/s43018-021-00326-1
Foersch S. & Lang-Schwarz C. & Eckstein M. & Geppert C. & Schmitt M. & Konukiewitz B. & Groll T. & Schicktanz F. & Engel J. & Gleitsmann M. & Westhoff C. C. & Frickel N. & Litmeyer A.-S. & Grass A. & Jank P. & Lange S. & Tschurtschenthaler M. & Wilhelm D. & Roth W. & Vieth M. & Denkert C. & Nagtegaal I. & Weichert W. & Jesinghaus M. (2022) pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassification in: British Journal of Cancer (127) 10.1038/s41416-022-01889-1
Gerber B. & Schneeweiss A. & Möbus V. & Golatta M. & Tesch H. & Krug D. & Hanusch C. & Denkert C. & Lübbe K. & Heil J. & Huober J. & Ataseven B. & Klare P. & Hahn M. & Untch M. & Kast K. & Jackisch C. & Thomalla J. & Seither F. & Blohmer J.-U. & Rhiem K. & Fasching P. A. & Nekljudova V. & Loibl S. & Kühn T. (2022) Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial in: Cancers (14) 10.3390/cancers14030521
Groll T. & Silva M. & Sarker R. S. J. & Tschurtschenthaler M. & Schnalzger T. & Mogler C. & Denk D. & Schölch S. & Schraml B. U. & Ruland J. & Rad R. & Saur D. & Weichert W. & Jesinghaus M. & Matiasek K. & Steiger K. (2022) Comparative Study of the Role of Interepithelial Mucosal Mast Cells in the Context of Intestinal Adenoma-Carcinoma Progression in: Cancers (14) 10.3390/cancers14092248
Heimbach B. & Schoner K. (2022) Fetalpathologie in: HebammenINFO (02/2022)
Herz A.-L. & Wisser S. & Kohlruss M. & Slotta-Huspenina J. & Jesinghaus M. & Grosser B. & Steiger K. & Novotny A. & Hapfelmeier A. & Schmidt T. & Gaida M. M. & Weichert W. & Keller G. (2022) Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact? in: The Journal of Pathology: Clinical Research (8) 10.1002/cjp2.257
Ihlow J. & Monjé N. & Hoffmann I. & Bischoff P. & Sinn B. V. & Schmitt W. D. & Kunze C. A. & Darb-Esfahani S. & Kulbe H. & Braicu E. I. & Sehouli J. & Denkert C. & Horst D. & Taube E. T. (2022) Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer in: Cancers (14) 10.3390/cancers14194620
Irqsusi M. & Mansouri A. L. & Ramaswamy A. & Rexin P. & Salman M. & Mahmood S. & Mirow N. & Ghazi T. & Ramzan R. & Rastan A. J. & Vogt S. (2022) Role of matrix metalloproteinases in mitral valve regurgitation: Association between the of MMP-1, MMP-9, TIMP-1, and TIMP-2 expression, degree of mitral valve insufficiency, and pathologic etiology in: Journal of Cardiac Surgery (37) 10.1111/jocs.16449
Jank P. & Lindner J. L. & Lehmann A. & Pfitzner B. M. & Blohmer J.-U. & Horst D. & Kronenwett R. & Denkert C. & Schmitt W. D. (2022) Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict) in: Breast Cancer Research and Treatment (191) 10.1007/s10549-021-06415-0
Jesinghaus M. & Boxberg M. & Schmitt M. & Kriegsmann M. & Harms A. & Lang C. & Muley T. & Winter H. & Kriegsmann K. & Warth A. & Stenzinger A. & Denkert C. & Hoffmann H. & Safi S. & Weichert W. (2022) Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading in: The Journal of Pathology. Clinical Research (8) 10.1002/cjp2.295
Jesinghaus M. & Herz A.-L. & Kohlruss M. & Silva M. & Grass A. & Lange S. & Novotny A. & Ott K. & Schmidt T. & Gaida M. & Hapfelmeier A. & Denkert C. & Weichert W. & Keller G. (2022) Post-neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage- and regression-grade independent prognostic information in intestinal-type gastric adenocarcinoma in: The Journal of Pathology. Clinical Research (8) 10.1002/cjp2.284
Jesinghaus M. & Poppinga J. & Lehman B. & Maurer E. & Ramaswamy A. & Grass A. & Di Fazio P. & Rinke A. & Denkert C. & Bartsch D. K. (2022) Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours in: Cancers (14) 10.3390/cancers14163963
Jurmeister P. & Glöß S. & Roller R. & Leitheiser M. & Schmid S. & Mochmann L. H. & Payá Capilla E. & Fritz R. & Dittmayer C. et al. (2022) DNA methylation-based classification of sinonasal tumors in: Nature Communications (13) 10.1038/s41467-022-34815-3
Keber C. U. & Derigs M. & Schultz C. & Wegner M. & Lingelbach S. & Wischmann V. & Hofmann R. & Denkert C. & Hegele A. & Hänze J. (2022) Cellular and soluble immune checkpoint signaling forms PD-L1 and PD-1 in renal tumor tissue and in blood in: Cancer immunology, immunotherapy: CII (71) 10.1007/s00262-022-03166-9
Kellers F. & Fernandez A. & Konukiewitz B. & Schindeldecker M. & Tagscherer K. E. & Heintz A. & Jesinghaus M. & Roth W. & Foersch S. (2022) Senescence-Associated Molecules and Tumor-Immune-Interactions as Prognostic Biomarkers in Colorectal Cancer in: Frontiers in Medicine (9)
Kirschbaum A. & Jonas J. & Surowiec T. M. & Pehl A. & Mirow N. (2022) Detection of the Lateral Thermal Spread during Bipolar Vessel Sealing in an Ex Vivo Model-Preliminary Results in: Diagnostics (Basel, Switzerland) (12) 10.3390/diagnostics12051217
Kirschbaum A. & Surowiec T. M. & Pehl A. & Wiesmann T. & Bartsch D. K. & Mirow N. (2022) Local lung coagulation post resection: an ex-vivo porcine model in: Lasers in Medical Science (37) 10.1007/s10103-021-03280-7
Klimovich B. & Meyer L. & Merle N. & Neumann M. & König A. M. & Ananikidis N. & Keber C. U. & Elmshäuser S. & Timofeev O. & Stiewe T. (2022) Partial p53 reactivation is sufficient to induce cancer regression in: Journal of experimental & clinical cancer research: CR (41) 10.1186/s13046-022-02269-6
Kolberg-Liedtke C. & Lüftner D. & Brucker S. Y. & Budach W. & Denkert C. & Fasching P. A. & Haidinger R. & Harbeck N. & Huober J. & Jackisch C. & Janni W. & Krug D. & Kühn T. & Loibl S. & Müller V. & Schneeweiss A. & Thomssen C. & Untch M. & Thill M. (2022) Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference in: Breast Care (Basel, Switzerland) (17) 10.1159/000517501
Kong W. & Albers M. B. & Manoharan J. & Goebel J. N. & Kann P. H. & Jesinghaus M. & Bartsch D. K. (2022) Pancreaticoduodenectomy Is the Best Surgical Procedure for Zollinger-Ellison Syndrome Associated with Multiple Endocrine Neoplasia Type 1 in: Cancers (14) 10.3390/cancers14081928
Konukiewitz B. & Jesinghaus M. & Kasajima A. & Klöppel G. (2022) Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls in: Virchows Archiv: An International Journal of Pathology (480) 10.1007/s00428-021-03211-5
Laakmann E. & Witzel I. & Neunhöffer T. & Park-Simon T. W. & Weide R. & Riecke K. & Polasik A. & Schmidt M. & Puppe J. & Mundhenke C. & Lübbe K. & Hesse T. & Thill M. & Zahm D. M. & Denkert C. & Fehm T. & Nekljudova V. & Rey J. & Loibl S. & Müller V. (2022) Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry in: ESMO Open (7) 10.1016/j.esmoop.2022.100495
Leichsenring J. & Vladimirova V. & Solbach C. & Karn T. & Ataseven B. & Sinn B. V. & Barinoff J. & Müller V. & Blohmer J.-U. & Schem C. & Engels K. & Marmé F. & Fisseler-Eckhoff A. & Fasching P. A. & Stickeler E. & van Mackelenbergh M. & Denkert C. & Stenzinger A. & Loibl S. & Gröschel S. (2022) EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy in: BMC cancer (22) 10.1186/s12885-022-10109-1
Li Z. & Wu Y. & Yates M. E. & Tasdemir N. & Bahreini A. & Chen J. & Levine K. M. & Priedigkeit N. M. & Nasrazadani A. & Ali S. & Buluwela L. & Arnesen S. & Gertz J. & Richer J. K. & Troness B. & El-Ashry D. & Zhang Q. & Gerratana L. & Zhang Y. & Cristofanilli M. & Montanez M. A. & Sundd P. & Wallace C. T. & Watkins S. C. & Fumagalli C. & Guerini-Rocco E. & Zhu L. & Tseng G. C. & Wagle N. & Carroll J. S. & Jank P. & Denkert C. & Karsten M. M. & Blohmer J.-U. & Park B. H. & Lucas P. C. & Atkinson J. M. & Lee A. V. & Oesterreich S. (2022) Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis in: Cancer Research (82) 10.1158/0008-5472.CAN-21-2576
Loevenich L. P. & Tschurtschenthaler M. & Rokavec M. & Silva M. G. & Jesinghaus M. & Kirchner T. & Klauschen F. & Saur D. & Neumann J. & Hermeking H. & Jung P. (2022) SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis. in: Cancer research (82) 10.1158/0008-5472.CAN-22-1247
Loi S. & Salgado R. & Adams S. & Pruneri G. & Francis P. A. & Lacroix-Triki M. & Joensuu H. & Dieci M. V. & Badve S. & Demaria S. & Gray R. & Munzone E. & Drubay D. & Lemonnier J. & Sotiriou C. & Kellokumpu-Lehtinen P. L. & Vingiani A. & Gray K. & André F. & Denkert C. & Piccart M. & Roblin E. & Michiels S. (2022) Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer in: npj Breast Cancer (8) 10.1038/s41523-021-00362-1
Loibl S. & Schneeweiss A. & Huober J. & Braun M. & Rey J. & Blohmer J.-U. & Furlanetto J. & Zahm D.-M. & Hanusch C. & Thomalla J. & Jackisch C. & Staib P. & Link T. & Rhiem K. & Solbach C. & Fasching P. A. & Nekljudova V. & Denkert C. & Untch M. & GBG and AGO-B (2022) Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response in: Annals of Oncology: Official Journal of the European Society for Medical Oncology (33) 10.1016/j.annonc.2022.07.1940
Mandic R. & Marquardt A. & Terhorst P. & Ali U. & Nowak-Rossmann A. & Cai C. & Rodepeter F. R. & Stiewe T. & Wezorke B. & Wanzel M. & Neff A. & Stuck B. A. & Bette M. (2022) The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC in: BMC Cancer (22) 10.1186/s12885-022-09854-0
Marchenko S. & Piwonski I. & Hoffmann I. & Sinn B. V. & Kunze C. A. & Monjé N. & Pohl J. & Kulbe H. & Schmitt W. D. & Darb-Esfahani S. & Braicu E. I. & von Brünneck A.-C. & Sehouli J. & Denkert C. & Horst D. & Jöhrens K. & Taube E. T. (2022) Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma in: Journal of Cancer Research and Clinical Oncology 10.1007/s00432-022-04101-2
Marr L. & Haller B. & Pyka T. & Peeken J. C. & Jesinghaus M. & Scheidhauer K. & Friess H. & Combs S. E. & Münch S. (2022) Predictive value of clinical and 18F-FDG-PET/CT derived imaging parameters in patients undergoing neoadjuvant chemoradiation for esophageal squamous cell carcinoma in: Scientific Reports (12) 10.1038/s41598-022-11076-0
Martin E. & Görg C. & Pehl A. & Safai Zadeh E. (2022) B-Mode Ultrasound Patterns of Systemic Silicone Disease in: Ultraschall in Der Medizin (Stuttgart, Germany: 1980) 10.1055/a-1816-6236
Mercan C. & Balkenhol M. & Salgado R. & Sherman M. & Vielh P. & Vreuls W. & Polónia A. & Horlings H. M. & Weichert W. & Carter J. M. & Bult P. & Christgen M. & Denkert C. & van de Vijver K. & Bokhorst J.-M. & van der Laak J. & Ciompi F. (2022) Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer in: NPJ breast cancer (8) 10.1038/s41523-022-00488-w
Möginger M. & Mand N. & Schoner K. & Seipelt M. & Schulze M. & Köhler S. & Axt-Fliedner R. & Keil C. N. (2022) [The Complexity of SARS-CoV-2 Infection in the Clinical Setting of Obstetrics - Discussion Based on a Case Study] in: Zeitschrift Für Geburtshilfe Und Neonatologie (226) 10.1055/a-1906-1937
Nauwelaers I. & Laudus N. & Peeters D. & Acs B. & Denkert C. & Michiels S. & Horlings H. & Siziopikou K. P. & Ely S. & Zardavas D. & Mustimbo R. & Bartlett J. & Floris G. & Hartman J. & van Deurzen C. H. M. & Ceusters D. & Dequeker E. & Salgado R. (2022) External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices in: Cancers (14) 10.3390/cancers14153762
Rehder H. & Schoner K. (2022) 2.12: Sonografisch festzustellende fetale Fehlbildungen, Dysplasien und Fehlbildungssyndrome in: Referenz Geburtshilfe und Perinatalmedizin (Edition: 1), Georg Thieme Verlag
Reinisch M. & Untch M. & Mahlberg R. & Reimer T. & Hitschold T. & Marmé F. & Aydogdu M. & Schmatloch S. & Lück H.-J. & Schmidt M. & Ladda E. & Sinn B. V. & Klare P. & Janni W. & Jackisch C. & Denkert C. & Seiler S. & Göhler T. & Michel L. & Burchardi N. & Stickeler E. & Rey J. & Klutinus N. & Möbus V. & Loibl S. (2022) Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study. in: Breast (Edinburgh, Scotland) (66) 10.1016/j.breast.2022.10.002
Romero R. & Zarzycka A. & Preussner M. & Fischer F. & Hain T. & Herrmann J.-P. & Roth K. & Keber C. U. & Suryamohan K. & Raifer H. & Luu M. & Leister H. & Bertrams W. & Klein M. & Shams-Eldin H. & Jacob R. & Mollenkopf H.-J. & Rajalingam K. & Visekruna A. & Steinhoff U. (2022) Selected commensals educate the intestinal vascular and immune system for immunocompetence in: Microbiome (10) 10.1186/s40168-022-01353-5
Safai Zadeh E. & Görg C. & Kuttkat P. & Dietrich C. F. & Westhoff C. C. & Rodepeter F. & Trenker C. & Görg M. & Kirschbaum A. & Alhyari A. (2022) The Value of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Perfusion Disturbances in Abdominal Wall Hernias Compared with Surgical and Histological Assessment in: Diagnostics (Basel, Switzerland) (12) 10.3390/diagnostics12020370
Safai Zadeh E. & Keber C. U. & Dietrich C. F. & Westhoff C. C. & Günter C. & Beutel B. & Alhyari A. & Trenker C. & Görg C. (2022) Perfusion Patterns of Peripheral Pulmonary Granulomatous Lesions Using Contrast-Enhanced Ultrasound (CEUS) and Their Correlation with Immunohistochemically Detected Vascularization Patterns in: Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine (41) 10.1002/jum.15730
Schmid P. & Cortes J. & Dent R. & Pusztai L. & McArthur H. & Kümmel S. & Bergh J. & Denkert C. & Park Y. H. & Hui R. & Harbeck N. & Takahashi M. & Untch M. & Fasching P. A. & Cardoso F. & Andersen J. & Patt D. & Danso M. & Ferreira M. & Mouret-Reynier M.-A. & Im S.-A. & Ahn J.-H. & Gion M. & Baron-Hay S. & Boileau J.-F. & Ding Y. & Tryfonidis K. & Aktan G. & Karantza V. & O’Shaughnessy J. (2022) Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer in: New England Journal of Medicine (386) 10.1056/NEJMoa2112651
Schmidt M. & Lübbe K. & Decker T. & Thill M. & Bauer L. & Müller V. & Link T. & Furlanetto J. & Reinisch M. & Mundhenke C. & Hoffmann O. & Zahn M.-O. & Müller L. & Denkert C. & van Mackelenbergh M. & Fasching P. A. & Burchardi N. & Nekljudova V. & Loibl S. (2022) A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE). in: ESMO open (7) 10.1016/j.esmoop.2022.100601
Schneeweiss A. & Michel L. L. & Möbus V. & Tesch H. & Klare P. & Hahnen E. & Denkert C. & Kast K. & Pohl-Rescigno E. & Hanusch C. & Link T. & Untch M. & Jackisch C. & Blohmer J.-U. & Fasching P. A. & Solbach C. & Schmutzler R. K. & Huober J. & Rhiem K. & Nekljudova V. & Lübbe K. & Loibl S. & GBG and AGO-B (2022) Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer in: European Journal of Cancer (Oxford, England: 1990) (160) 10.1016/j.ejca.2021.10.011
Schult D. & Reitmeier S. & Koyumdzhieva P. & Lahmer T. & Middelhoff M. & Erber J. & Schneider J. & Kager J. & Frolova M. & Horstmann J. & Fricke L. & Steiger K. & Jesinghaus M. & Janssen K.-P. & Protzer U. & Neuhaus K. & Schmid R. M. & Haller D. & Quante M. (2022) Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19 in: Gut Microbes (14) 10.1080/19490976.2022.2031840
Staudte S. & Klinghammer K. & Jurmeister P. S. & Jank P. & Blohmer J.-U. & Liebs S. & Rhein P. & Hauser A. E. & Tinhofer I. (2022) Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers in: Cancers (14) 10.3390/cancers14112810
Stögbauer F. & Lautizi M. & Kriegsmann M. & Winter H. & Muley T. & Kriegsmann K. & Jesinghaus M. & Baumbach J. & Schüffler P. & Weichert W. & Kacprowski T. & Boxberg M. (2022) Tumour cell budding and spread through air spaces in squamous cell carcinoma of the lung - Determination and validation of optimal prognostic cut-offs in: Lung Cancer (Amsterdam, Netherlands) (169) 10.1016/j.lungcan.2022.04.012
Tarawneh T. S. & Rodepeter F. R. & Teply-Szymanski J. & Ross P. & Koch V. & Thölken C. & Schäfer J. A. & Gremke N. & Mack H. I. D. & Gold J. & Riera-Knorrenschild J. & Wilhelm C. & Rinke A. & Middeke M. & Klemmer A. & Romey M. & Hattesohl A. & Jesinghaus M. & Görg C. & Figiel J. & Chung H.-R. & Wündisch T. & Neubauer A. & Denkert C. & Mack E. K. M. (2022) Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board in: Cancers (14) 10.3390/cancers14184430
Trenker C. & Görg C. & Burchert A. & Michel C. & Kipper K. & Westhoff C. C. & Keber C. U. & Safai Zadeh E. (2022) Presentation of Chloromas in B-Mode Ultrasound and Contrast-Enhanced Ultrasound in: Ultrasound in Medicine & Biology (48) 10.1016/j.ultrasmedbio.2022.05.024
Wagner B. R. & Adamus A. L. & Hempfling L. & Vahdad R. & Haap-Hoff A. & Heinrich B. & Vázquez O. & Jank P. & Denkert C. & Seitz G. (2022) Increasing the efficiency of hyperthermic intraperitoneal chemotherapy (HIPEC) by combination with a photosensitive drug in pediatric rhabdomyosarcoma in an animal model in: Pediatric Blood & Cancer (69) 10.1002/pbc.29864
Wege A. K. & Rom-Jurek E.-M. & Jank P. & Denkert C. & Ugocsai P. & Solbach C. & Blohmer J.-U. & Sinn B. & van Mackelenbergh M. & Möbus V. & Trumpp A. & Marangoni E. & Pfarr N. & Irlbeck C. & Warfsmann J. & Polzer B. & Weber F. & Ortmann O. & Loibl S. & Vladimirova V. & Brockhoff G. (2022) mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease in: International Journal of Cancer (150) 10.1002/ijc.33911
Welz L. & Kakavand N. & Hang X. & Laue G. & Ito G. & Silva M. G. & Plattner C. & Mishra N. & Tengen F. & Ogris C. & Jesinghaus M. & Wottawa F. & Arnold P. & Kaikkonen L. & Stengel S. & Tran F. & Das S. & Kaser A. & Trajanoski Z. & Blumberg R. & Roecken C. & Saur D. & Tschurtschenthaler M. & Schreiber S. & Rosenstiel P. & Aden K. (2022) Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis in: Gastroenterology (162) 10.1053/j.gastro.2021.09.057
Wild P. J. & Denkert C. & Jackisch C. (2022) [Predictive molecular diagnostics in breast cancer : What are the requirements for pathology today and in the future?] in: Pathologie (Heidelberg, Germany) (43) 10.1007/s00292-022-01096-y
Zöller G. & Dellmann C. & Rodepeter F. & Görg C. & Metzelder S. (2022) [Alveolar echinococcosis (fox tapeworm)-a surprising diagnosis in a patient with epididymal tumor] in: Urologie (Heidelberg, Germany) (61) 10.1007/s00120-022-01775-x
Mintziras I. & Peer K. & Goerlach J. & Goebel J. N. & Ramaswamy A. & Slater E. P. & Kann P. H. & Bartsch D. K. (2021) Adult Proinsulinomatosis Associated With a MAFA Germline Mutation as a Rare Cause of Recurrent Hypoglycemia in: Pancreas (50) 10.1097/MPA.0000000000001933